Catalyst Funds Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$879K Sell
4,700
-4,780
-50% -$879K 0.05% 307
2026
Q1
$1.79M Buy
+9,480
New +$2M 0.3% 92
2025
Q4
Sell
-3,900
Closed -$792K 564
2025
Q3
$792K Sell
3,900
-1,900
-33% -$337K 0.12% 168
2025
Q2
$1.02M Buy
+5,800
New +$873K 0.28% 105
2025
Q1
Sell
-10,900
Closed -$1.38M 584
2024
Q4
$1.38M Buy
10,900
+2,300
+27% +$342K 0.34% 63
2024
Q3
$1.43M Buy
+8,600
New +$1.3M 0.31% 55

Other funds holding THC

Catalyst Funds Management's THC Position: Q2 2026 in Review

Catalyst Funds Management reduced its Tenet Healthcare (THC) stake by 50% in Q2 2026, selling an estimated $879K and leaving 4,700 shares worth $879K. The position accounts for 0.05% of the portfolio, ranked #307.

Catalyst Funds Management first reported a position in THC in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.79M in Q1 2026. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Catalyst Funds Management held 4,700 shares of Tenet Healthcare worth $879K as of Q2 2026.
  • Catalyst Funds Management sold 4,780 Tenet Healthcare shares in Q2 2026, an estimated $879K.
  • Tenet Healthcare made up 0.05% of Catalyst Funds Management's portfolio in Q2 2026, its #307 holding.
  • Catalyst Funds Management first reported a position in Tenet Healthcare in Q3 2024 and has held it in 6 quarters since.
  • Catalyst Funds Management's Tenet Healthcare position peaked at $1.79M in Q1 2026.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.